Taking Aim at Cancer Costs
Health Alliance Plan (HAP), a Detroit-based regional health plan, is among a handful of payers experimenting with different payment models and protocols for the treatment of cancers.
According to a study that appeared last year in the New England Journal of Medicine, annual direct costs for cancer care will increase by $69 billion to $173 billion in 2020. Among the cost drivers is the increased cost of therapies. The sales of anti-cancer drugs are second only to those for heart disease.
HAP, along with Cardinal Health Specialty Solutions and Physician Resource Management, an oncology physician consulting firm, are working together on an evidence-based clinical pathways program that it hopes will improve the treatment quality and lower the costs of cancer care.
Cardinal Health Specialty Solutions will provide education and training and the technology used by HAP physicians to implement and monitor the program. PRM is assisting in physician recruitment.
- Resisting the Healthcare Consolidation Frenzy
- Give Nurses in Wheelchairs a Chance
- New G-Codes to Pay Doctors for Broad Array of Non-Face-to-Face Care
- 3 Better Ways to Market Bariatric Surgery
- HL20: George Halvorson—Expectations for Success
- MGMA Urges 'End-to-End' ICD-10 Testing
- Top 3 Health Plan Game Changers of 2013
- Scary Financial Challenges for 2014
- MU Compliance Announcement Sparks Concern, Confusion
- Q&A: Ardis Dee Hoven 'Optimistic' SGR Will Be Repealed